BridgeMD
New treatment option for Myopia Progression
Official title The Effect of Myopia-Control Contact Lenses in New Zealand Chinese Children
ClinicalTrials.gov ID: NCT07535749
What this study is testing
- What it's testing
- The study will employ a randomized, controlled, investigator-masked paired-eye comparison design to evaluate the effects of two myopia-control contact lenses-MiSight 1 Day and Abiliti 1-Day-in New Zealand Chinese children. The study duration will be 6 months, with assessments conducted at baseline, 2 weeks, 3 months, and 6 months.
- Phase 3: a large, late-stage study
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 7 to 11
You may be able to join if
- Spherical refractive error between -1.00D and -4.50D
- Astigmatism of ≤1.00D
- No history of orthokeratology or atropine use
- No ocular diseases or surgical history
You likely can't join if
- o No ocular diseases or surgical history
The study team makes the final eligibility decision.
Where it's taking place
- Auckland, New Zealand
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 7 years to 11 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Auckland, New Zealand. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.